000 | 01132 a2200349 4500 | ||
---|---|---|---|
005 | 20250513140738.0 | ||
264 | 0 | _c19980416 | |
008 | 199804s 0 0 eng d | ||
022 | _a0887-6924 | ||
024 | 7 |
_a10.1038/sj.leu.2400915 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVicari, A M | |
245 | 0 | 0 |
_aAcute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. _h[electronic resource] |
260 |
_bLeukemia _cMar 1998 |
||
300 |
_a441-2 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitoxantrone _xadverse effects |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 | _aTopoisomerase II Inhibitors |
700 | 1 | _aCiceri, F | |
700 | 1 | _aFolli, F | |
700 | 1 | _aLanzi, R | |
700 | 1 | _aColombo, B | |
700 | 1 | _aComi, G | |
700 | 1 | _aCamba, L | |
773 | 0 |
_tLeukemia _gvol. 12 _gno. 3 _gp. 441-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2400915 _zAvailable from publisher's website |
999 |
_c9496765 _d9496765 |